Search

everythinglearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

New and repurposed treatments are improving outcomes in dermatology.

Sex hormones may affect COVID-19 severity and outcomes.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

Pharmacists play a crucial role in patient care and optimizing treatment outcomes.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Adipose tissue and PRP together improve healing and surgery outcomes but need more research for consistent use.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Current SLE classifications need refinement, and the complement system is a key therapeutic target.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Advancements in understanding, diagnosing, and managing congenital adrenal hyperplasia have improved treatment and long-term outcomes.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

New insights into skin damage from UV exposure suggest potential treatments, including targeting specific RNAs and combining therapies for better outcomes.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Improved dermabrasion techniques in 1987 led to better treatment results for skin issues like acne scars.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Nanoparticle drug delivery could improve alopecia areata treatment.

Platelet-rich plasma can aid tissue repair but faces challenges in standardization.

Ethosomes can safely and effectively deliver various drugs deep into the skin.

Herbal formula shows promise for hair loss treatment.

SPARC-modified stem cells significantly improve dog skin wound healing.

The review found that PRP is the most effective treatment for hair loss with few side effects.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Spanlastics improve drug delivery by enhancing bioavailability and targeting, reducing side effects.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.